OBJECTIVES: Cavitary disease and bilateral lesions are among the risk factors for poor outcome of pulmonary tuberculosis (TB). Our aim was to explore the value and limits of surgery in patients with advanced TB.
INTRODUCTION
Drug-resistant tuberculosis (TB) is a major challenge to TB control in Europe and globally due to the high incidence of multidrugresistant (MDR) TB. Fifteen of 27 countries with a high burden of MDR TB worldwide are in Eastern Europe. In 2011, Russia was 1 of 9 European countries reporting 10-30% of all TB cases that were MDR TB [1, 2] . Until the 1950s, surgery was the only available treatment for TB. Since the 1970s, most of the patients with TB were cured by taking the TB drugs, that became available [1] . However, the seemingly defeated disease returned as MDR and extensively drug-resistant (XDR) TB, causing surgery to re-emerge as an important tool in the treatment of TB [3] .
Treatment success rates for MDR TB and especially for XDR TB are disappointing even in high-income countries [4, 5] . Cavitary TB disease [6] and bilateral lesions [2, 5, [7] [8] [9] are the risk factors for poor outcome. In well-localized bilateral cases of TB, usually the lung with the most extensive lesion is targeted [10] . However, most patients with bilateral TB are rejected as candidates for surgery [8, 9, 11] , which, in the presence of M/XDR TB, leaves them only a vague chance for a cure.
Our aim was to explore the value and limits of surgery in patients with bilateral cavitary MDR or XDR TB.
PATIENTS AND METHODS
A retrospective case series of consecutive patients undergoing surgery for bilateral cavitary M/XDR TB at St. Petersburg State Research Institute of Phthisiopulmonology was carried out. We reviewed case records of patients who underwent hospital admission and surgical treatment between 1 October 2012 and 30 April 2015 and the data covering the follow-up period (1 January 2013 -28 February 2017 .
Patients were included in the study when all the following criteria were met:
1. The presence of thick-walled TB cavities with fibrosis and TB lesions in the surrounding pulmonary tissue, which is a definition for fibrous cavitary TB, or 'fibrocavernous tuberculosis'. 2. At least 1 segment on each side was affected with cavitary TB lesions that were greater than 1.0 cm. 3. MDR TB confirmed by analysis of TB cultures (defined as resistance to at least isoniazid and rifampicin) or confirmation of XDR TB (defined as MDR with additional resistance to ofloxacin and any second-line injectable drug) in at least 1 of 3 cultures obtained within 6 months prior to admission.
On admission, sputum was retested for acid-fast bacilli and cultures. The drug susceptibility of Mycobacterium tuberculosis isolates to isoniazid 1.0 mg/ml; rifampicin 40 mg/ml; streptomycin 10 mg/ml; ethambutol 2 mg/ml; kanamycin 30 mg/ml; capreomycin 30 mg/ml, prothionamide 30 mg/ml; cycloserine 30 mg/ml; para-aminosalicylic acid 1.0 mg/ml and ofloxacin 2.0 mg/ml was determined with Löwenstein-Jensen medium using the absolute concentration method. Susceptibility to pyrazinamide was determined using Bactec MGIT 960 at a concentration of 100 mg/ml.
Fifty-seven eligible patients were detected. Forty-four (77.2%) patients were men and 13 (22.8%) were women; the patients were in the age range of 18-61 (median 33) years. All patients were HIV negative. Twenty-two patients had MDR TB and 35 had XDR TB, confirmed with cultures. Resistance to 3-8 (average 5.3) and 6-10 (average 8.0) TB drugs was observed in patients with MDR and XDR TB, respectively. All patients had experienced the failure of at least 1 full course of treatment prior to admission; 5 patients had previously undergone unilateral partial pulmonary resection for TB, followed by disease relapse. At least 6 months to 3 years of the best available TB therapy according to M. tuberculosis drug susceptibility was carried out before surgery.
The preoperative data of the patients with MDR and XDR TB are given in Table 1 .
All patients underwent evaluation for surgery, including plain chest radiograph, chest computed tomography scan, echocardiography, spirometry, lung perfusion-ventilation scan, bronchoscopy, arterial blood gas analysis, blood chemistry and coagulation tests. Forced expiratory volume in 1 s below 1.5 or 2.0 l rendered the patient non-eligible for lobectomy or pneumonectomy, respectively.
The main indication for surgery in all cases was treatment failure, manifested as contagious bilateral pulmonary cavities, persisting despite best available medical treatment. In 5 cases, pulmonary haemorrhages occurred and were an additional indication for surgery.
Diagnostic bronchoscopy was performed under local anaesthesia in all patients, with special focus on bronchi in the region of the planned surgery. When an endobronchial TB lesion or area of significant non-specific inflammation was found, the operation was postponed until the bronchial affection settled down.
Operations were performed under general anaesthesia using a double-lumen endotracheal tube and single-lung ventilation. Video-assisted typical segmentectomies (SE, n = 8) and lobectomies (LE, n = 2), occasionally robotic-assisted lobectomies (n = 3), were performed. Lateral thoracotomy access was used to accomplish extended pulmonary resections: lobectomy + segmentectomy (LE + SE, n = 5) or segmentectomy + segmentectomy (SE + SE, n = 3) and pneumonectomies (PE, n = 28), including 5 completion pulmonary resections. In the presence of dense adhesions, we preferred thorough extrapleural lung dissection, avoiding unexpected injury of underlying TB cavities. The needle electrode was routinely used for dissection and coagulation. The bronchial stump was closed with mechanical sutures and was routinely reinforced with mediastinal fat in all cases of PE. Bronchial stump reinforcement with a serratus (n = 6) or diaphragm (n = 2) muscle flap was used in patients who had a high-sputum acid-fast bacilli load preoperatively and/or endobronchial TB sequelae. All removed lesions were sent for pathological examination and culture.
Selective thoracoplasty (STP, n = 28) was accomplished from a postero-lateral, extrapleural minithoracotomy. Full removal of the first and second ribs and sub-total resection of the third and fourth ribs were carried out.
Endobronchial valve (EBV) treatment (n = 44) was performed as a supplement to another operation or as an independent intervention. The valve was placed in the bronchi of the affected segment/lobe during bronchoscopy for 3 months, as described by Levin et al. [12] . However, defined inflammatory and cicatrical malformation and/or the conical shape of the appropriate segmental/lobar bronchi made the patient ineligible for EBV.
The volume and sequence of surgical procedures were determined by the extent of TB pulmonary affection and the patient's functional status. Seven patients with MDR and 1 patient with XDR TB presented with well-localized bilateral disease. Cavitary lesions were located mostly within the upper lobes, and the total extent of TB affection covered fewer than 10 segments in total and maximally 6 segments on the dominant side. They all had good pulmonary function results and were eligible for consecutive lung resections. We defined them as Group A. Eight patients with MDR TB and 20 with XDR TB presented with 1 lung destroyed (considered to be 6 or more segments in the left lung or 8 or more segments in the right lung affected with cavitary lesions, with decrease of blood perfusion in the affected lung to 20% and below), along with contralateral cavitary disease, limited to 3 segments. These patients comprised Group B.
Twenty-one patients were not eligible for bilateral resection due to extensive sub-total cavitary disease affecting 14 or more lung segments (n = 15, 11 had XDR TB) or due to poor pulmonary function (n = 6, 3 had XDR TB). Mostly palliative interventions (STP and/or EBV) were performed in this group. We combined those variable cases in Group C.
After the operation, intensive phase of TB therapy was resumed once patients were able to take medications per os. Mostly, it was the same as their preoperative regimen.
Each patient was re-evaluated before any subsequent operations. The evaluation included another chest computed tomography scan, spirometry and arterial blood gas analysis.
An initial follow-up visit occurred 1 month after the last operation it included a chest radiograph and computed tomography scan, sputum smears and cultures. Further smears were taken at least once monthly; cultures and radiographs were taken every 2nd month during the intensive phase of treatment. When 2 consecutive negative sputum cultures were obtained, patients proceeded to the treatment continuation phase. During the latter, cultures and radiographs were obtained at least every 3 months. We defined culture negativation as 4 or 5 consecutive negative sputum cultures in patients with MDR and XDR TB, respectively. At least 12 months of medical treatment, including at least 6 months of intensive phase treatment, were administered after the last operation. Late follow-up was done on 28 February 2017.
Statistical analysis
The database containing the patients' information was managed in Windows Excel 2003. The Fisher's exact test or the v 2 test was used to estimate categorical data. A P-value of <0.05 was regarded as statistically significant. This study was approved by the institutional review board of St. Petersburg State Research Institute of Phthisiopulmonology, and written informed consent was obtained from every participant.
RESULTS
In Group A, the first-stage operation was performed on the side most affected. Stepwise ipsilateral LE + SE and contralateral SE (n = 3) and consecutive bilateral SE (n = 1) were performed. The average follow-up period between ipsilateral and contralateral surgery was 36 days. However, we observed the obliteration of contralateral cavities in the remaining 4 patients after unilateral lobectomy (n = 2), right upper LE + SE (n = 1) and left upper lobe SE (n = 1) were performed.
In Group B, ipsilateral PE (n = 11) or completion PE (n = 3) was the first-stage surgery, followed by contralateral STP and/or EBV (n = 14). However, contralateral EBV was a first-stage intervention in the other 14 (50.0%) patients who had marginal results from spirometry and lung perfusion. Between 1 and 2 months following EBV (average 38 days), second-stage ipsilateral PE (n = 12) or completion PE (n = 2) was performed. After a follow-up period of 21-211 (average 82.7) days, the third-stage operation was accomplished. Consecutive contralateral EBV and STP (n = 10) and occasionally right upper LE (n = 1) or SE (n = 2) were carried out. Interestingly, the left lung was destroyed in 20 (71.4%) cases, 14 of whom were patients with XDR TB (P = 0.35).
In Group C, consecutive bilateral STP was accomplished in 6 patients with XDR TB. Unilateral STP and contralateral EBV were performed in 3 patients with MDR and 5 with XDR TB. One patient underwent bilateral EBV. However, we applied staged ipsilateral LE (n = 2) or LE + SE (n = 4) and contralateral EBV (n = 5) or STP (n = 1) in Group C patients with poor pulmonary function and limited TB affection.
No deaths occurred in the 1st year. One patient in Group B died secondary to a household accident 12 months after pneumonectomy. The patient in Group C with sub-total cavitary lesions and XDR to 9 drugs died of TB progression 24 months after the last-stage operation.
Average duration for LE/SE, PE and STP was 112 (80-150), 240 (140-385) and 131 (110-170) min, respectively. The average intraoperative blood loss for LE/SE, PE and STP was 135 (100-250), 413.0 (80.0-2000.0) and 240 (180-300) ml, respectively. Two patients with 700 and 2000 ml blood loss during PE due to difficult lung dissection received blood transfusions (1 dose per patient).
For those with a non-complicated postoperative course, the intensive care unit stay was 3-5 (average 4.6) days after pneumonectomy and 1 day after LE/SE and thoracoplasties. The average chest drainage time after uneventful SE/LE was 2.4 (2.0-3.0) days. Ten major complications (1 complication per patient, 17.5% complication rate) developed. Data are given in Table 2 .
The total follow-up duration varied between 20 and 36 months. No patients were lost to follow-up. We estimated smear negativation at early follow-up visits and culture negativation at late follow-up visits. Data are given in Tables 3 and 4 .
DISCUSSION
The impact of surgery, as an important tool in the treatment of TB during the preantibiotic era, is commonly accepted [3] . The role of adjunctive thoracic surgery in the treatment of MDR/XDR TB is presently not evidence based [1, 4] .
Pulmonary resection for MDR-TB can be considered a neoadjuvant procedure, the goal of which is to remove a major burden of tubercle bacilli contained within destroyed pulmonary tissue [13] . The same can be stated, but not without some reservations, regarding XDR TB. Since 2006, reports of series of pulmonary resections for XDR TB were published [6, 9, 10, [13] [14] [15] . However, the lack of susceptible drugs may render surgery for XDR-TB as risky as it was in the preantibiotic era [16] . Along with cavitary disease, XDR TB itself is associated with poor treatment outcome [9] .
Presently, the failure of medical treatment to cure patients with pulmonary M/XDR TB, defined as the inability to convert sputum cultures to negative despite the best available treatment scheme, is recognized as the main indication for surgery [5, 8, 13, 14, 16, 17] . Another common indication for surgery is a smear/ culture negative M/XDR TB with a high probability of possible relapse [8, 13, 16] . Extensive lung affection [8] and cavitary TB lesions [10, 17] are considered among the top reasons for the latter. Our patients matched both indications. All of them remained culture positive for TB to the moment of admission, and most (n = 49, 86.0%) of them were sputum acid-fast bacilli positive. Each patient had at least 1 full course of MDR/XDR medical treatment failure, and most of them spent more than 2 years in TB treatment prior to surgery without improvement. A compelling reason for considering those cases for surgery was evidence of the futility of further therapy, because they remained infectious despite the best available medical treatment.
In addition, 49 (86.0%) patients had extensive TB lesions with fibrous cavities in both lungs, including 28 (49.1%) patients who presented with 1 lung destroyed due to MDR/XDR TB, thus suggesting surgery as the only promising tool to achieve recovery.
However, no definite opinion regarding surgical treatment of bilateral cavitary lesions is currently available. Published guidelines consider surgical treatment for unilateral TB, which renders the decision for bilateral TB thoracic surgery an individual one [18, 19] .
In a number of articles, well-localized unilateral MDR/XDR TB lesions are regarded as appropriate for surgery [1, 2, 6, 7, 10, 20] . Successful bilateral pulmonary resections for such lesions have also been reported [14, 17, 20, 21] .
In our series, 8 (14.0%) patients presented with well-localized bilateral cavitary TB lesions (Group A); only 1 was XDR TB. We planned bilateral resection surgery starting with the most affected lung. Shortly thereafter, we observed contralateral cavity closure in half of the cases, making further surgery unnecessary. This finding agrees with the experiences of other authors who initially intended unilateral resection at the most affected side with medical management for contralateral lesion [13, 15] . Our data suggest that a breakthrough in the course of bilateral cavitary disease appeared only after the most affected TB site was removed.
To support this opinion, poor treatment outcome was reported for those patients in whom some TB cavities were located outside the line of lung resection and thus were not removed [22] . We may suppose that radical unilateral surgery on the dominant side increases the chances of success of subsequent medical treatment by significantly reducing the bacillary burden of M. tuberculosis.
However, few patients in our series demonstrated limited bilateral cavities. In 12 (54.5%) patients with MDR and 31(88.6%) patients with XDR TB, the extensive TB lesions prevailed, including destroyed lung and sub-total cavitary affection.
Complete lung destruction along with limited contralateral cavitary lesions was detected in 28 (49.1%) patients (Group B). Because the patients faced irreversible changes in the most affected lung, a first-stage pneumonectomy was required, followed by second-stage contralateral surgery on the single remaining lung.
In large case studies, pneumonectomy is mentioned among the common operations performed for advanced MDR/XDR TB [3, 10, 14, 20, [22] [23] [24] . However, significant contralateral TB is often regarded as ineligible for surgery in the candidates for pneumonectomy [5, 9, 21] . A predicted preoperative forced expiratory volume in 1 s of at least 2.0 l is mentioned among the basic criteria of fitness for pneumonectomy [15, 19] . This criterion is uncommon among patients with MDR/XDR TB who have a long history of failing TB treatment, putting them beyond a selection bias as non-surgical patients [11] . Still, some articles reported successful pneumonectomy followed by contralateral pulmonary resection [3, 10, 25] for advanced bilateral cavitary MDR/XDR TB.
In this study, 28 pneumonectomies (including 5 completion pulmonary resections) were accomplished, 20 (74.2%) of which were left sided. Contralateral right upper LE (n = 1) or SE (n = 2) of the remaining lung was performed. In the others, contralateral palliative surgery was performed.
Interestingly, left destroyed lung prevailed among the patients in Group B. The 'left side syndrome' in patients undergoing pneumonectomy for TB was described and explained with anatomical features of the left main bronchus that made the left lung vulnerable to TB [24, 26] .
One half of the Group B patients had marginal results of spirometry, making them minimally eligible for surgery. For this reason, we performed EBV in the remaining lung as a Stage 1 procedure. We expected that a severe increase in respiratory impairment secondary to EBV, once it occurred, would become the evident predictor of a poor outcome of surgery. Thus, too risky multistage surgical interventions might be avoided. We observed severe respiratory insufficiency in 1 patient after an uneventful first-stage PE followed by final-stage STP. However, no statistically significant difference in the prevalence of complications in subgroups with various sequences of surgery was found.
A bronchial stump fistula is an oppressive complication after PE, meaning a relapse of TB [16] . However, protective bronchial stump reinforcement with mediastinal fat or a muscular flap is an effective measure to minimize the occurrence of this complication [3, 16, 27] . We performed reinforcement with local tissue (e.g. mediastinal fat) in all patients with PE and performed muscular flap reinforcement when the possibility of fistula formation was high. We observed 4 (14.3%) patients with main bronchus stump fistula. In 1 case, we performed muscular reinforcement during bronchial stump re-resection on the day of fistula formation. In 2 other cases, which occurred early in this study, we used a levofloxacin-based drug regimen with the intratracheal introduction of part of the daily dose. In the late series, we prescribed levofloxacin inhalations for all the patients with PE at risk for fistula formation who had this drug in their treatment scheme. A similar decision to use a fluoroquinolone-containing regimen was published [24] . Several authors reported similar or higher rates of postoperative bronchial fistula [8, 14, 21, 26] .
We failed to find a statistically significant influence of age, gender, social status, comorbidities and MDR/XDR on the occurrence of postoperative main bronchus stump fistula. However, a more prolonged air leak prevailed in patients following extended pulmonary resections (n = 3, 37.5%) than in those who had LE or SE alone. This finding is predictable and may be explained by the fact that a large portion of the pulmonary surface is affected during dissection in the extended resections and with minimally invasive access in LE/SE. However, a small number of cases require further investigation in a large comparable group to study this complication.
Every third patient in our study was ineligible for bilateral pulmonary resection (Group C). In selected cases, we accomplished unilateral lobar or segmental resection on the most affected side, followed by contralateral palliative interventions. By following this approach, we expected that further medical treatment would be successful after the first-stage operation. We failed to show an effect of an operation on the dominant side similar to that seen in Group A in our series due to the small number of observations.
In most patients in Group C, only bilateral palliative surgery was carried out. The interventions included staged selective unilateral or bilateral thoracoplasty, followed by contra-or bilateral EBV. Thoracoplasties are still routinely performed for TB in former USSR countries [19, 25, 28] . Pulmonary resection is preferred over thoracoplasty, because the latter is associated with postoperative progressive respiratory failure [3] . However, patients in Group C were not eligible for pulmonary resection. Therefore, the choice was between thoracoplasty and medical treatment only rather than between palliative and radical surgery.
At initial postoperative follow-up visits, smear conversion was achieved in 11 of 16 (68.8%) patients with MDR TB and in 15 of 33 (45.5%) patients with XDR TB, while culture negativation was gained in all but 1 patient with MDR TB and in the majority of patients with XDR TB, resulting in a reasonable treatment outcome in comparison with the commonly accepted success rate [5] with acceptable rates of morbidity and mortality.
In this study, patients with XDR TB and MDR TB had similar preoperative anatomical and functional characteristics. Patients with XDR TB tended to be older and to have previous imprisonment history. Predictably, the duration of treatment prior to surgery was shorter in patients with MDR TB, who were less likely to have primary drug resistance and were more likely to be cured.
Limitations
The study has several limitations.
First, no control group of patients with bilateral cavitary MDR and XDR TB, treated with therapy only, was available for this study. However, since late 2013, such patients should be regarded as subjects for possible TB surgery after 6 months of unsuccessful TB therapy [19] . Patients treated for cavitary MDR/ XDR TB with therapy only tend to have very low pulmonary function levels and/or advanced disease, making them ineligible for surgery. Other reasons for patients with MDR/XDR TB to obtain therapy only include severe comorbidity, poor patient compliance and patient refusal to have surgery. Hence, finding a representative control group of patients with bilateral cavitary MDR/XDR TB might introduce a selection bias between patients who are non-compliant and those with incurable TB.
Second, the need for bilateral surgery for limited cavitary lesions requires further evaluation. The potential for non-interventional closure of contralateral cavities after the first-stage operation is known [15] . However, the duration of therapy following the first-stage operation that is suitable before it is time to decide about the next-stage operation requires evaluation. Possible exacerbation of TB secondary to mistiming should not be underestimated.
The duration of preoperative medical treatment is open for discussion. The dominant opinion is that the best possible therapy should last at least 3 months preoperatively [20, 26] . However, it is difficult to elaborate a common rule for heterogeneous groups of patients with TB [3] . In some patients with MDR/ XDR TB, negative sputum culture results cannot be achieved without the surgical resection of the infected lung [18] .
CONCLUSIONS
The study data suggest that thoracic surgery may result in curing most patients with bilateral cavitary MDR TB and may significantly improve the outcome in patients with bilateral cavitary XDR TB, with acceptable rates of morbidity and mortality. Pulmonary resection is the surgery of choice in patients with localized bilateral MDR/XDR TB cavitary disease, and when applicable, should be preferred to other surgical interventions in advanced bilateral cavitary TB.
Significant differences in the results of surgery for MDR and XDR TB support the importance of timely interventional treatment decision making in patients with advanced drug-resistant TB with potentially failing medical treatment.
Our results show that complex and frequently successful thoracic surgery should be considered as the essential element of multimodality treatment for MDR and XDR TB even in patients with bilateral cavitary disease and borderline respiratory reserves.
